Our study revealed that Mettl3 deficiency in hepatocytes mediated m6A modification regulated lipid metabolism and non-alcoholic fatty liver disease (NAFLD) progression by significantly downregulating genes related to lipid metabolism. The gene discussed is METTL3; the disease is metabolic dysfunction-associated steatotic liver disease.